A leading pediatrician in the United Kingdom recently claimed that medical professionals in the United States are “out of date” regarding hormonal and surgical interventions for trans-identified minors. Last month, Dr. Hilary Cass published a landmark study titled the “Cass Report,” which caused the National Health Service to order its gender clinics to issue a pause on first appointments for those under 18, The Christian Post reports.
Cass, who has worked as a pediatrician in England for over 30 years, was tasked with reviewing the country’s process for treating young people suffering from gender dysphoria. For the study, she interviewed minor patients, transgender-identifying adults, de-transitioners, advocacy groups, and clinicians; she also reviewed international healthcare guidance.
Despite the lack of long-term studies on the use of puberty-blocking drugs and cross-sex hormones, there has been a significant increase in minors in the U.K. seeking treatment for their gender dysphoria throughout the past decade.
In conclusion, Cass concluded that there is “remarkably weak” evidence supporting puberty blockers for adolescents and warned that such hormones should be prescribed with “extreme caution.”
However, the American Academy of Pediatrics (AAP) and the Endocrine Society seemed to downplay Cass’ findings in the study.
“According to The New York Times, politicians have inserted themselves into the exam room, which is dangerous for both physicians and for familie
